Provided by Tiger Trade Technology Pte. Ltd.

Ascendis Pharma A/S

263.04
+15.136.10%
Post-market: 263.040.00000.00%17:07 EDT
Volume:1.03M
Turnover:269.94M
Market Cap:17.41B
PE:20.30
High:268.98
Open:247.65
Low:247.65
Close:247.91
52wk High:282.15
52wk Low:186.05
Shares:66.19M
Float Shares:65.54M
Volume Ratio:3.65
T/O Rate:1.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):12.96
EPS(LYR):-4.4176
ROE:118.78%
ROA:9.58%
PB:10.43
PE(LYR):-59.54

Loading ...

Ascendis Pharma Reports Solid Yorvipath Quarter; Yuviwel Off to Strong Start, RBC Says

MT Newswires Live
·
Aug 14

Ascendis Pharma is Maintained at Overweight by Barclays

Dow Jones
·
Aug 14

Ascendis Pharma (ASND) Receives a Buy from Cantor Fitzgerald

TIPRANKS
·
Aug 14

RBC Adjusts PT on Ascendis Pharma to $290 From $280, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 14

Ascendis Pharma (ASND) Receives a Buy from Wells Fargo

TIPRANKS
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Ascendis Pharma (ASND)

TIPRANKS
·
Aug 14

Ascendis Pharma a/S : Jefferies Raises Target Price to $333 from $325

THOMSON REUTERS
·
Aug 14

Analysts Are Bullish on These Healthcare Stocks: ProMIS Neurosciences (PMN), Ascendis Pharma (ASND)

TIPRANKS
·
Aug 14

Ascendis Pharma's Long-Term Potential Intact, Wedbush Says

MT Newswires Live
·
Aug 14

European Equities Traded in the US Rise in Thursday Trading

MT Newswires Live
·
Aug 13

Ascendis Pharma A/S Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Sector Update: Healthcare Stocks Advance Pre-Bell Thursday

MT Newswires Live
·
Aug 13

Ascendis Pharma's Q2 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Aug 13

Earnings Flash (ASND) Ascendis Pharma Posts Q2 Non-IFRS EPS 0.90 Euros, vs. FactSet Est of 1.80 Euros

MT Newswires Live
·
Aug 13

Ascendis Pharma Q2 Revenue EUR 339.3 Million

THOMSON REUTERS
·
Aug 13

Ascendis Pharma Q2 FY26 Swings to Net Profit of €207 Million; Revenue More than Doubles to €339 Million

Reuters
·
Aug 13

Ascendis Pharma Q2 Adj. EPS $1.05 Beats $0.78 Estimate, Sales $394.437M Beat $353.800M Estimate

Benzinga Earnings
·
Aug 13

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 13

Ascendis Pharma A/S Expected to Post Earnings of €1.38 a Share - Earnings Preview

Reuters
·
Aug 11

Cantor Fitzgerald Reaffirms Their Buy Rating on Ascendis Pharma (ASND)

TIPRANKS
·
Aug 08